SCHEMBL6920765

SCHEMBL6920765

O=c1c2ccc(-c3ccc(F)cc3)cc2nc2n1CCOC2

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.43
NPC1 O15118 5/20 0.43
LMNA P02545 1/20 0.43
GRM2 Q14416 3/20 0.41
ALDH1A1 P00352 2/20 0.41
POLB P06746 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
USP2 O75604 1/20 0.38
TP53 P04637 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CSNK1D P48730 1/20 0.37
CSNK1E P49674 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6921979 0.90 PRKDC (0.39) RAB9ANPC1ALDH1A1POLBSMN1; SMN2
SCHEMBL6920903 0.89 ALDH1A1 (0.47) RAB9ANPC1LMNAGRM2ALDH1A1
SCHEMBL12059543 0.87 CYP3A4 (0.40) RAB9ANPC1LMNAGRM2ALDH1A1
SCHEMBL6920542 0.85 RAB9A (0.41) RAB9ANPC1LMNAGRM2ALDH1A1
SCHEMBL6922253 0.80 RAB9A (0.63) RAB9ANPC1LMNAALDH1A1SMN1; SMN2
SCHEMBL6920833 0.80 NPC1 (0.43) RAB9ANPC1LMNAALDH1A1POLB
SCHEMBL6921589 0.79 NPC1 (0.42) RAB9ANPC1ALDH1A1POLBSMN1; SMN2
SCHEMBL6923306 0.78 RAB9A (0.43) RAB9ANPC1LMNAGRM2ALDH1A1
SCHEMBL6921941 0.78 GRM2 (0.40) RAB9ANPC1LMNAGRM2ALDH1A1
SCHEMBL12059556 0.78 RAB9A (0.43) RAB9ANPC1LMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075699-A2 COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2011-06-23 WO disclosed